MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,449,000 | +93.5% | 40,000 | +135.3% | 0.73% | +107.4% |
| Q2 2019 | $1,782,000 | +136.3% | 17,000 | -37.0% | 0.35% | +128.8% |
| Q1 2019 | $754,000 | -66.5% | 27,000 | +35.0% | 0.15% | -77.0% |
| Q4 2018 | $2,254,000 | -24.8% | 20,000 | +42.9% | 0.66% | +23.4% |
| Q3 2018 | $2,998,000 | -59.5% | 14,000 | -47.2% | 0.54% | -62.2% |
| Q2 2018 | $7,411,000 | +252.6% | 26,499 | +47.2% | 1.42% | +97.9% |
| Q1 2018 | $2,102,000 | – | 18,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
| Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
| ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
| HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
| Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
| EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
| GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
| SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
| ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |